Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plerixafor for Stem Cell Mobilization in SCD
NCT04817345Phase 2Withdrawn
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Apr 2023
- Primary completion
- Apr 2023
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of plerixafor in sickle cell disease (SCD), sponsored by St. Jude Children's Research Hospital. Planned start Apr 2023; status: withdrawn.
02
Drugs
plerixafor
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT04817345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04817345.